Manufacturers Life Insurance Company, The Vera Therapeutics, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $100 Billion
- Q1 2025
A detailed history of Manufacturers Life Insurance Company, The transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 141,409 shares of VERA stock, worth $2.96 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
141,409
Previous 128,380
10.15%
Holding current value
$2.96 Million
Previous $5.43 Million
37.45%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding VERA
# of Institutions
196Shares Held
63.9MCall Options Held
723KPut Options Held
186K-
Avoro Capital Advisors LLC New York, NY5.7MShares$119 Million2.22% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.75MShares$99.4 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$69.8 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$61.9 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.92MShares$61 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $565M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...